The effect of inhibition of EGFR transactivation in renal (patho)physiological processes
PhD ceremony: Ms. G.M. Mulder, 16.15 uur, Academiegebouw, Broerstraat 5, Groningen
Dissertation: The effect of inhibition of EGFR transactivation in renal (patho)physiological processes
Promotor(s): prof. H. van Goor, prof. J.L. Hillebrands
Faculty: Medical Sciences
This thesis explored and emphasized the role of the EGFR transactivation pathway in renal physiology and pathophysiological processes. Inhibition of the EGFR activation pathway can be a suitable intervention therapy during and after renal transplantation and in the treatment of (cardiovascular complications in) renal diseases. New drugs that interfere in the EGFR activation pathway can possibly contribute to reducing the rejection risk following renal transplantation and be useful in the treatment of renal diseases.
| Last modified: | 13 March 2020 01.01 a.m. |
More news
-
27 August 2024
UMCG gaat onderzoeksfaciliteiten beschikbaar stellen voor geneesmiddelenontwikkeling
Om de beschikbaarheid en effectiviteit van geneesmiddelen in Nederland te verbeteren gaat het UMCG het bedrijf G² Solutions opzetten. Dit bedrijf moet ervoor gaan zorgen dat belangrijke technologische ontwikkelingen op het gebied van DNA sequencing...
-
17 July 2024
Veni-grants for ten researchers
The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.
-
16 July 2024
Medicine still subjects to male bias
Aranka Ballering studied the course of illness in people with common symptoms. One of the most striking findings to emerge from her research was that on average, women have a different – and less extensive – course of illness than men.